Daiichi Sankyo has launched a new direct-to-consumer (DTC) campaign for Enhertu — the first DTC effort for its oncology unit ...

The NHS England has announced the routine commissioning of Daiichi Sankyo's quizartinib for acute myeloid leukaemia (AML).

Osaka Metropolitan University researchers analyzed the incidence in Japan of COVID-19-associated pulmonary aspergillosis ...

TOKYO (AP) — Japan and China announced Friday that they have reached a deal resolving their disputes over the discharge of treated radioactive wastewater from the tsunami-hit Fukushima Daiichi nuclear ...

Today’s positive decision follows the manufacturer, Daiichi Sankyo, offering a fair price for the treatment that the National Institute for Health and Care Excellence (NICE) determined to be ...

NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...

Merck MRK announced that a phase study evaluating its Daiichi Sankyo-partnered HER3-directed DXd antibody drug conjugate (ADC ...

Well, we tend to launch in Europe first. And I think this is what you're seeing ... KEYTRUDA with one of the ADCs that we partnered with, whether it's Kulun or Daiichi Sankyo. And we're very excited ...

This summary covers significant updates in the health sector, including US Senator Bernie Sanders' push for cheaper generic ...

The major U.S. index futures are currently pointing to a modestly higher open on Wednesday, with stocks likely to move to the upside ...

Daiichi Sankyo and MSD (Merck & Co) have reported that the Phase III HERTHENA-Lung02 clinical trial of patritumab deruxtecan, ...